Literature DB >> 12609847

Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain.

Jenny Odeberg1, Bodo Plachter, Lars Brandén, Cecilia Söderberg-Nauclér.   

Abstract

Human cytomegalovirus (HCMV) has developed multiple strategies to escape immune recognition. Here, we demonstrate that HCMV down-regulates HLA-DR expression in infected interferon gamma (IFN-gamma)-stimulated fibroblasts at 1 day after infection. Decreased HLA-DR expression was not observed on cells infected with an HCMV strain lacking the pp65 gene (RVAD65), but was observed on cells transfected with the pp65 gene. HLA-DR expression accumulated in vacuoles near the nucleus in HCMV-infected, but not in uninfected or RVAD65-infected cells. In addition, the HLA-DR alpha-chain, but not the beta-chain or HLA-DM, was degraded in HCMV-infected but not in RVAD65-infected cells. Thus, the HCMV protein pp65 mediates decreased expression of HLA-DR, by mediating an accumulation of HLA class II molecules in lysosomes that results in degradation of the HLA-DR alpha-chain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609847     DOI: 10.1182/blood-2002-05-1504

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

Review 1.  The ins and outs of MHC class II-mediated antigen processing and presentation.

Authors:  Paul A Roche; Kazuyuki Furuta
Journal:  Nat Rev Immunol       Date:  2015-02-27       Impact factor: 53.106

2.  Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells.

Authors:  Jenny Odeberg; Nina Wolmer; Scott Falci; Magnus Westgren; Ake Seiger; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

4.  Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion.

Authors:  Maaike E Ressing; Daphne van Leeuwen; Frank A W Verreck; Sinéad Keating; Raquel Gomez; Kees L M C Franken; Tom H M Ottenhoff; Melanie Spriggs; Ton N Schumacher; Lindsey M Hutt-Fletcher; Martin Rowe; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression.

Authors:  Joanne Trgovcich; Colleen Cebulla; Pete Zimmerman; Daniel D Sedmak
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 6.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

7.  Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.

Authors:  Zhiguo Sun; Hem Chandra Jha; Yong-Gang Pei; Erle S Robertson
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

8.  Human Cytomegalovirus Infection Dysregulates the Localization and Stability of NICD1 and Jag1 in Neural Progenitor Cells.

Authors:  Xiao-Jun Li; Xi-Juan Liu; Bo Yang; Ya-Ru Fu; Fei Zhao; Zhang-Zhou Shen; Ling-Feng Miao; Simon Rayner; Stéphane Chavanas; Hua Zhu; William J Britt; Qiyi Tang; Michael A McVoy; Min-Hua Luo
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

9.  Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.

Authors:  Tarin M Bigley; Justin M Reitsma; Shama P Mirza; Scott S Terhune
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.

Authors:  Jianmin Zuo; Andrew D Hislop; Carol S Leung; Shereen Sabbah; Martin Rowe
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.